Cargando…

Cannabidiol and Other Cannabinoids in Demyelinating Diseases

A growing body of preclinical evidence indicates that certain cannabinoids, including cannabidiol (CBD) and synthetic derivatives, may play a role in the myelinating processes and are promising small molecules to be developed as drug candidates for management of demyelinating diseases such as multip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarrete, Carmen, García-Martín, Adela, Rolland, Alain, DeMesa, Jim, Muñoz, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001020/ https://www.ncbi.nlm.nih.gov/pubmed/33804243 http://dx.doi.org/10.3390/ijms22062992

Ejemplares similares

Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
por: Martínez, Vicente, et al.
Publicado: (2020)

Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
por: Kozela, Ewa, et al.
Publicado: (2017)

Detrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice
por: Carmona-Hidalgo, Beatriz, et al.
Publicado: (2021)

Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease
por: Burgaz, Sonia, et al.
Publicado: (2021)

Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
por: Nahler, Gerhard
Publicado: (2022)

Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
por: Casares, Laura, et al.
Publicado: (2019)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

Spinal Cord Involvement in MS and Other Demyelinating Diseases
por: Marrodan, Mariano, et al.
Publicado: (2020)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

Cannabinoid non-cannabidiol site modulation of TRPV2 structure and function
por: Zhang, Liying, et al.
Publicado: (2022)

A cannabidiol aminoquinone derivative activates the PP2A/B55α/HIF pathway and shows protective effects in a murine model of traumatic brain injury
por: Navarrete, Carmen, et al.
Publicado: (2022)

Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review
por: Trac, Judy, et al.
Publicado: (2021)

Multiple Sclerosis and Other Demyelinating Diseases
por: Soldan, Samantha S., et al.
Publicado: (2008)

A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy
por: Katz, Daphna T., et al.
Publicado: (2023)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review
por: Soufi, Khadija H., et al.
Publicado: (2023)

α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabissativa
por: Suttithumsatid, Wiwit, et al.
Publicado: (2022)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Effects of Cannabidiol on Locomotor Activity
por: Calapai, Fabrizio, et al.
Publicado: (2022)

Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells
por: Kozela, Ewa, et al.
Publicado: (2016)

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
por: Mammana, Santa, et al.
Publicado: (2019)

Cannabidiol markedly alleviates skin and liver fibrosis
por: del Río, Carmen, et al.
Publicado: (2022)

Topical Administration of Ibuprofen for Injured Athletes: Considerations, Formulations, and Comparison to Oral Delivery
por: Manoukian, Martin Anthony Christopher, et al.
Publicado: (2017)

Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro
por: Milian, Lara, et al.
Publicado: (2020)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Cannabis sativa (Henola Variety) Inflorescences
por: Stasiłowicz-Krzemień, Anna, et al.
Publicado: (2023)

Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives
por: Götz, Marcus R., et al.
Publicado: (2019)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

A Critical Review of the Role of the Cannabinoid Compounds Δ(9)-Tetrahydrocannabinol (Δ(9)-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
por: Jones, Éamon, et al.
Publicado: (2020)

Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells
por: Kozela, Ewa, et al.
Publicado: (2015)

Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB(2) Receptors
por: Martínez-Pinilla, Eva, et al.
Publicado: (2017)

Macrophages and Autoantibodies in Demyelinating Diseases
por: Koike, Haruki, et al.
Publicado: (2021)

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
por: Navarrete, Carmen, et al.
Publicado: (2018)

Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
por: Xiong, Yinyi, et al.
Publicado: (2021)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations
por: Pavlovic, Radmila, et al.
Publicado: (2018)

Notes from the Field: Acute Poisonings from a Synthetic Cannabinoid Sold as Cannabidiol — Utah, 2017–2018
por: Horth, Roberta Z., et al.
Publicado: (2018)

Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC–MS
por: Jeong, Minsun, et al.
Publicado: (2023)

Effect of vaporizing cannabis rich in cannabidiol on cannabinoid levels in blood and on driving ability – a randomized clinical trial
por: Egloff, Laura, et al.
Publicado: (2023)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b6bu8tuuqr3h4mite3l0n7se6h